ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Diagnostic Tests"

  • Abstract Number: 2617 • 2015 ACR/ARHP Annual Meeting

    Serum 14-3-3eta Protein Elevation in Osteoarthritis Suggests Misclassification or Concurrent Inflammatory Arthritis

    Olga S. Zhukov1, Jonnielyn G. Rivera1, Rania W. Abolhosn1, Robert J. Lagier2, Charles M. Rowland3, Joanna M. Popov1, Kaleb Michaud4 and Stanley J. Naides1, 1Immunology, Quest Diagnostics Nichols Institute, San Juan Capistrano, CA, 2Research Support, Alameda, Quest Diagnostics Alameda, Alameda, CA, 3Research Support, Quest Diagnostics Alameda, Alameda, CA, 4Rheumatology & Immunology, University of Nebraska Medical Center and National Data Bank, Omaha, NE

    Background/Purpose: Tissue distribution of the chaperonin 14-3-3η (eta) is limited to synovial tissue and brain. Synovium releases proinflammatory 14-3-3η into synovial fluid and serum in…
  • Abstract Number: 1995 • 2014 ACR/ARHP Annual Meeting

    Design and Implementation of a Clinical Teaching Tool for Approach to Children with Suspected New Rheumatologic Diagnosis

    Kristen Hayward1 and Jennifer Hrachovec2, 1Pediatric Rheumatology, Seattle Children's Hospital, Seattle, WA, 2Clincal Effectiveness, Seattle Children's Hospital, Seattle, WA

    Background/Purpose Approximately 1 in 1000 children suffer from a rheumatologic disorder. Despite the relative frequency of these conditions, there is a shortage of pediatric rheumatologists…
  • Abstract Number: 1867 • 2014 ACR/ARHP Annual Meeting

    Mandibular Movement in Healthy Individuals from 4-17 Years of Age

    Peter Stoustrup1, Kasper Dahl Kristensen2,3, Annelise Küseler4, Thomas Klit Pedersen5,6 and Troels Herlin7, 1Section of Orthodontics, University of Aarhus, Aarhus C, Denmark, 2Section of Orthodontics, University of Aarhus, Denmark, 8000 Aarhus, Denmark, 3Specialist Oral Health Center for Western Norway, Rogaland Stavanger, Norway, 4Section of Orthodontics, Aarhus University, Aarhus, Denmark, 5Section or Orthodontics, Aarhus University, Aarhus, Denmark, 6Department of Oral and Maxillofacial Surgery, Aarhus University Hospital, Aarhus, Denmark, 7Pediatric Rheumatology Clinic, Department of Pediatrics, Aarhus University Hospital, Aarhus, Denmark

    Background/Purpose: Assessment of mandibular movement capacity is an important part of the clinical orofacial examination of patients with juvenile idiopathic arthritis (JIA). The aim of…
  • Abstract Number: 1756 • 2014 ACR/ARHP Annual Meeting

    Molecular Diagnosis Reveals a Surprising Prevalence of Limited Gpa Among Patients with Orbital Inflammatory Diseases

    James T. Rosenbaum1, Dongseok Choi2, Christine Harrington3, Patrick Stauffer4, David Wilson5, Seema Gupta4, Roger Dailey4, John Ng4, Eric Steele4, Patrick Yeatts6, Peter Dolman7, Valerie White7, Gerald Harris8, Craig Czyz9, Jill Foster9, Deepak Edward10, Hind Alkatan10, Bobby Korn11, Don Kikkawa12, Dinesh Selva13, Sander Dubovy14, Chris Alabiad15, David Tse15, Michael Kazim16, Payal Patel16 and Stephen R. Planck17, 1OHSU, Portland, OR, 2Casey Eye Institute, Oregon Health and Science University, Portland, OR, 3Integrated Genomics, Oregon Health & Science University, Portland, OR, 4Oregon Health & Science University, Portland, OR, 5Casey Eye Institute/Ophthalmology, Oregon Health & Science University, Portland, OR, 6Ophthalmology, Wake Forest University, Winston-Salem, NC, 7University of British Columbia, Vancouver, BC, Canada, 8Medical College of Wisconsin, Milwaukee, WI, 9Ohio State Univeristy, Columbus, OH, 10King Khaled Eye Hospital, Riyadh, Saudi Arabia, 11University of California, San Diego, San Diego, CA, 12Ophthalmology, University of California, San Diego, San Diego, CA, 13Royal Adelaide Hospital, Adelaide, Australia, 14University of Miami, Miami, FL, 15Ophthalmology, University of Miami, Miami, FL, 16Columbia University, New York City, NY, 17Casey Eye Inst/Ophthalmology, Oregon Health & Science University, Portland, OR

    Background/Purpose: Gene expression profiling provides diagnostic and therapeutic information in several malignancies, but its role in evaluating inflammatory disease is relatively untested. We hypothesized that…
  • Abstract Number: 1762 • 2014 ACR/ARHP Annual Meeting

    The Muscle Biopsy Is a Useful and Noninvasive Procedure in Diagnosing Systemic Vasculitis Affecting Small-to-Medium-Sized Vessels: A Prospective Evaluation

    Takahiro Nunokawa1, Takayasu Kise1, Naoto Yokogawa2, Kota Shimada1 and Shoji Sugii2, 1Department of Rheumatic diseases, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan, 2Department of Rheumatic Diseases, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan

    Background/Purpose: Histopathological confirmation is required for the diagnosis of systemic vasculitis. However, patients suspected of vasculitis often only have lesions with a low diagnostic yield…
  • Abstract Number: 1695 • 2014 ACR/ARHP Annual Meeting

    Validation of Vesmeter As a Diagnostic Tool of Scleroderma

    Yoshihiro Hishitani1,2, Yoshihito Shima1, Toshio Tanaka1 and Atsushi Kumanogoh1, 1Respiratory Medicine, Allergy and Rheumatic Diseases, Osaka University Graduate School of Medicine, Suita, Japan, 2Internal Medicine, Kinki Central Hospital, Itami, Japan

    Background/Purpose: Objective method to evaluate the skin involvement in the patients with scleroderma has not been definitely established. We have developed Vesmeter, a computer-linked device…
  • Abstract Number: 1691 • 2014 ACR/ARHP Annual Meeting

    Systemic Sclerosis Patients with Pulmonary Hypertension Have a Lower Change in End Tidal Carbon Dioxide Following Three Minutes of Step Exercise Than Systemic Sclerosis Patients without Pulmonary Hypertension: A Cross-Sectional Study

    Elana J. Bernstein1, Jessica K. Gordon2, Robert F. Spiera2, Wei-Ti Huang3, Evelyn M. Horn4 and Lisa A. Mandl2, 1Rheumatology, Columbia University College of Physicians & Surgeons, New York, NY, 2Rheumatology, Hospital for Special Surgery, New York, NY, 3Biostatistics, Hospital for Special Surgery, New York, NY, 4Cardiology, New York Presbyterian Hospital/Weill Cornell Medical College, New York, NY

    Background/Purpose: Pulmonary hypertension (PH) is a leading cause of death in patients with systemic sclerosis (SSc).  Transthoracic echocardiogram and pulmonary function testing are standard noninvasive…
  • Abstract Number: 1629 • 2014 ACR/ARHP Annual Meeting

    Added Value of the Determination of Anti-Ribosomal and Anti-Ku Antibodies for Diagnosis of Systemic Lupus Erythematosus

    Johannes Schulte-Pelkum1, Diana Carmona-Fernandes2, Maria Jose Santos2, Roger Albesa1 and Michael Mahler1, 1Research, INOVA Diagnostics, San Diego, CA, 2Rheumatology Research Unit Instituto de Medicina Molecular, Faculty of Medicine, University of Lisbon, Lisbon, Portugal

    Background/Purpose Anti-dsDNA antibodies (aab) are known as important serological marker to aid in the diagnosis of systemic lupus erythematosus (SLE) and are part of the…
  • Abstract Number: 1421 • 2014 ACR/ARHP Annual Meeting

    Preclinical Interstitial Lung Disease in Early Rheumatoid Arthritis

    Javier Narváez1, Alejandro Robles Perez2, Maria Molina Molina3 and Joan Miquel Nolla4, 1Rheumatology, Hospital Universitario de Bellvitge. Barcelona. Spain, Barcelona, Spain, 2Pneumology, Hospital Universitario de Bellvitge, Barcelona, Spain, 3Hospital Universitario de Bellvitge, Barcelona, Spain, 4Rheumatology, Hospital Universitario de Bellvitge, Barcelona, Spain

    Background/Purpose: Early detection and treatment of interstitial lung disease (ILD) in patients with rheumatoid arthritis (RA) may ameliorate disease progression. The objective of the present…
  • Abstract Number: 1309 • 2014 ACR/ARHP Annual Meeting

    Does Anti-C1q Antibody Have Diagnostic and Prognostic Roles in Childhood – Onset Systemic Lupus Erythematosus?

    Thaschawee Arkachaisri1, Joo Guan Yeo2, Justin Hung Tiong Tan3, Sook Fun Hoh4, Lena Das3 and Jing Yao Leong2, 1Rheumatology & Immunology, KK Women's and Children's Hospital, Singapore, Singapore, 2Children Intensive Care Unit (CICU), KK Women's and Children's Hospital, Singapore, Singapore, 3Rheumatology and Immunology, KK Women's and Children's Hospital, Singapore, Singapore, 4Nursing, KK Women's and Children's Hospital, Singapore, Singapore

    Background/Purpose: Biomarkers proven to be effective in aSLE patients may not directly apply to cSLE unless validation is done. Existing evidences have shown immunopathogenic roles…
  • Abstract Number: 2772 • 2014 ACR/ARHP Annual Meeting

    The Use of Imaging in the Diagnosis of Polymyalgia Rheumatica: Systematic Literature Review and Meta-Analysis

    Sarah Mackie1, Gouri Koduri2, Catherine L. Hill3,4, Andrew Hutchings5, Richard J. Wakefield6, Bhaskar Dasgupta7 and Jeremy Wyatt8, 1NIHR-Leeds Musculoskeletal Biomedical Research Unit, University of Leeds, Leeds, United Kingdom, 2Rheumatology, York Teaching Hospital NHS Foundation Trust, York, United Kingdom, 3Rheumatology Unit, The Queen Elizabeth Hospital, Woodville, Australia, 4Discipline of Medicine, University of Adelaide, Adelaide, Australia, 5Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, United Kingdom, 6NIHR-Leeds Musculoskeletal Biomedical Research Unit and Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom, 7Department of Rheumatology, Southend University Hospital, Essex, United Kingdom, 8Leeds Insitute of Health Sciences, University of Leeds, Leeds, United Kingdom

    Background/Purpose ACR/EULAR provisional classification criteria for polymyalgia rheumatica (PMR) incorporate musculoskeletal ultrasound of shoulder and hip (bursitis and synovitis given equal weight). Our objective was…
  • Abstract Number: 1308 • 2014 ACR/ARHP Annual Meeting

    Antinucleosome Antibodies As Potential Diagnostic and Prognostic Biomarkers in Childhood Onset Systemic Lupus Erythematosus

    Thaschawee Arkachaisri1, Joo Guan Yeo2, Justin Hung Tiong Tan3, Sook Fun Hoh4, Lena Das3 and Jing Yao Leong2, 1Rheumatology & Immunology, KK Women's and Children's Hospital, Singapore, Singapore, 2Children Intensive Care Unit (CICU), KK Women's and Children's Hospital, Singapore, Singapore, 3Rheumatology and Immunology, KK Women's and Children's Hospital, Singapore, Singapore, 4Nursing, KK Women's and Children's Hospital, Singapore, Singapore

    Background/Purpose: The role of antinucleosome antibodies (ANuA) in the immunopathogenesis of SLE is evident. ANuA was shown to be a good, if not better than…
  • Abstract Number: 2588 • 2014 ACR/ARHP Annual Meeting

    Which Characteristics of Inflammatory Back Pain (CBP) Forecast the Presence of HLA-B27? Results from the Esperanza Cohort

    Victoria Navarro-Compán1, Juan Jose Aznar2, Luis F Linares3, Eduardo Collantes-Estévez4, Robert B. M. Landewé5, Désirée van der Heijde6 and Pedro Zarco7, 1Rheumatology, University Hospital La Paz and Leiden University Medical Center, Madrid, Spain, 2Hospital de Mérida, Mérida (Badajoz), Spain, 3University Hospital Virgen de la Arrixaca, Murcia, Spain, 4IMIBIC/University Hospital Reina Sofía, Córdoba, Spain, Córdoba, Spain, 5Department of Rheumatology, Amsterdam Rheumatology Center, Amsterdam, Netherlands, 6Leiden University Medical Center, Leiden, Netherlands, 7Rheumatology Department, Fundación Hospital Alcorcon, Alcorcon, Madrid, Spain

    Background/Purpose: CBP is often the starting point for a suspicion of axSpA. In the ASAS-criteria for axial SpA either MRI of the SI-joints or HLA-B27-testing…
  • Abstract Number: 1258 • 2014 ACR/ARHP Annual Meeting

    Enzyme-Linked Immunosorbent Assays for Detection of Anti-Transcriptional Intermediary Factor-1 Gamma and Anti-Mi-2 Autoantibodies in Dermatomyositis: Utility and Crossreactivity

    Manabu Fujimoto1, Akihiro Murakami2, Shunsuke Kurei2, Akiko Kuwajima3, Yasuhiro Fujisawa1, Atsushi Kawakami4, Michiaki Mishima5, Shinji Sato6, Mariko Seishima7, Takafumi Suda8, Tsuneyo Mimori9, Kazuhiko Takehara10 and Masataka Kuwana11, 1Department of Dermatology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan, 2Medical & Biological Laboratories Co., Ltd, Nagaya, Japan, 3Medical & Biological Laboratories Co.,Ltd., Nagoya, Japan, 4Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan, 5Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan, Kyoto, Japan, 6Division of Rheumatology, Department of Internal Medicine, Tokai University School of Medicine, Isehara, Japan, 7Department of Dermatology, Gifu University Graduate School of Medicine, Gifu, Japan, 8Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan, 9Dept of Rheum & Clinical Immunology, Kyoto Univ Grad Schl of Med, Kyoto, Japan, 10Dermatology, Kanazawa University, Kanazawa, Japan, 11Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan

    Background/Purpose Anti-transcriptional intermediary factor 1 (TIF-1) and anti-Mi-2 antibodies (Abs) are myositis-specific autoantibodies (MSA) selectively detected in dernatomyositis (DM) patients. Anti-TIF-1 Ab is frequently found…
  • Abstract Number: 2586 • 2014 ACR/ARHP Annual Meeting

    Which Characteristics of Inflammatory Back Pain (CBP) Forecast the Presence of Sacroiliitis on Magnetic Resonance Imaging (MRI)? Results from the Esperanza Cohort

    Victoria Navarro-Compán1, Raquel Almodóvar González2, Azucena Hernández3, Emma Beltrán4, Eugenio De Miguel5, Robert B. M. Landewé6, Désirée van der Heijde7 and Pedro Zarco8, 1Rheumatology, University Hospital La Paz and Leiden University Medical Center, Madrid, Spain, 2Rheumatology Unit, Hospital Universitario Fundación Alcorcón, Madrid, Spain, 3Rheumatology, Hospital Virgen de la Salud, Toledo, Spain, 4University General Hospital of Valencia, Valencia, Spain, 5Rheumatology, University Hospital La Paz - IdiPaz, Madrid, Spain, 6Department of Rheumatology, Amsterdam Rheumatology Center, Amsterdam, Netherlands, 7Leiden University Medical Center, Leiden, Netherlands, 8Rheumatology Department, Fundación Hospital Alcorcon, Alcorcon, Madrid, Spain

    Background/Purpose: CBP is often the starting point for a suspicion of axSpA. In the ASAS-criteria for axial SpA either MRI of the SI-joints or HLA-B27-testing…
  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology